On Monday, the Appellate Board upheld the compulsory licence granted to domestic firm Natco Pharma last year, against Bayer's patented anti-cancer drug Nexavar.
Bayer will not accept a ruling by the Intellectual Property Appellate Board in Chennai on Monday, upholding the compulsory licence granted on March 9 last year and it will appeal against the patent office order at the high court in Mumbai, a spokesperson told PTI.
The venue of the battle by Swiss multinational Novartis AG against the rejection of its patent application for blockbuster cancer drug Gleevac will now shift to the Patent Appellate Board's office.
The order comes in response to a petition filed by Jaguar Cars Ltd seeking to quash the decision of deputy registrar of Trade Marks, Kolkata.
Oncologist Dr Sthabir Dasgupta talks about the impact of Novartis's losing patent case on the Indian pharma industry.
In July this year, the Intellectual Property Appellate Board had directed Registrar of Trademarks to cancel Amul's registration of TRIX trademark.
Novartis's famed cancer drug, Glivec, will not get patent protection in India. The apex body on patent and trademark disputes, the Intellectual Property Appellate Board (IPAB), has ruled that the drug "lacks innovation" and the high price tag of Rs 120,000 per month per patient would be too high for the common man.
Perfetti has won the suit against Candico that was filed 9 years ago over the latter's trademark.
Although the revocation application was filed in August, it takes time for the Apellate Board to send notices and hence, TVS took upon itself to inform BAL about the same.
Software major Infosys Technologies Ltd on Thursday said it would contest the ruling by the Chennai bench of the Intellectual Property Appellate Board, which has held that it cannot hold a monopoly on the trademark 'Infosys.'
India rejects patent on Pfizer's arthritis drug
Govt to scrap 8 appellate tribunals; National Company Law Appellate Tribunal to take over Competition Appellate Tribunal's duties
The application (of Deccani Biryani Makers Association) for registration of 'Hyderabadi Biryani' in Geographical Indications is treated as abandoned "for want of prosecution", as they (applicant) have failed to prove the historical data and origin of the product with supporting documents, the officials at the GI registry in Chennai, held in its order issued on January 27 this year.
Before opening its first outlet in the country on November 9, the US fast food chain, Burger King Corporation, had approached the HC seeking an assurance that companies it had sued for trademark infringement will not approach lower courts for stay orders against its launch.
India's Supreme Court in April rejected a patent for Novartis AG's cancer drug Glivec, saying it was an amended version of a known molecule called imatinib, setting the precedent for more such cases in the country.
.jpg)
The environment ministry till May 2014 (still under UPA) ordered that cases like Vedanta's expansion plans need to consult people. But in December 2014, the NDA government reversed this position and in March 2015 the environment ministry extended Vedanta's environmental clearance till December 2018. This it did even while the question of the need for public hearing by projects in different kinds of industrial parks was being contested in the courts. This allowed the company to carry out construction.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances